Medscape

Device May Improve Outcomes in Chronic Rhinitis

Ablation of the posterior nasal nerve using the NEUROMARK system led to greater reductions in nasal symptoms and improvements ...
gut.bmj

Treatment of non-constipated irritable bowel syndrome with the histamine 1 receptor antagonist ebastine: a randomised, double-blind, placebo-controlled trial

Correspondence to Professor Guy Boeckxstaens, Department of Chronic Diseases, Metabolism, and Ageing, KU Leuven, Leuven, Belgium; guy.boeckxstaens{at}kuleuven.be Objective We evaluated the histamine 1 ...
clinicaladvisor.com

Seasonal Allergies and OTC Nasal Sprays

The incidence of provider-diagnosed AR in the United States is approximately 60 million people, including both adults and children. 2 The incidence is even higher when patients self-report AR: between ...
Hosted on MSN

VAS has comparable validity for perennial allergic, nonallergic rhinitis

TUESDAY, Dec. 30, 2025 (HealthDay News) -- The visual analog scale (VAS) demonstrates comparable validity for perennial allergic rhinitis (PAR) and nonallergic rhinitis (NAR) severity and ...
Medical Xpress

Visual analog scale has comparable validity for perennial allergic, nonallergic rhinitis

The visual analog scale (VAS) demonstrates comparable validity for perennial allergic rhinitis (PAR) and nonallergic rhinitis (NAR) severity and quality-of-life (QoL) impairment, according to a study ...
Mena FN

Allergic Rhinitis Pipeline 2025: Therapies Under Investigation, Clinical Trials Milestones, And FDA Approvals By Delveinsight Inmunotek, Iltoo Pharma, Advagene Biopharma Co ...

(MENAFN- GetNews) (Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Allergic Rhinitis pipeline constitutes 35+ key companies continuously working towards developing 35+ ...